Valproic acid induces differentiation of a supratentorial primitive neuroectodermal tumor.
In preclinical models the antiepileptic drug valproic acid induces differentiation of neoplastic cells, representing an evolving anticancer approach that takes into account that malignant cells resemble immature progenitor cells capable of terminal differentiation. The authors report on a child suffering from a relapsing supratentorial primitive neuroectodermal tumor that received valproic acid for epilepsy treatment over 7 months before the relapse. In contrast to the initial tumor, the relapsing tumor showed glial differentiation and low proliferation index. This is the first report of a relapsed supratentorial primitive neuroectodermal tumor that shows histologically confirmed signs of tumor cell differentiation induction.
Driever
P Hernáiz
PH
Department of Pediatric Oncology, Campus Virchow Hospital, Charité Universitätsmedizin-Berlin, Berlin, Germany. pablo.hernaiz@charite.de
Wagner
S
S
Hofstädter
F
F
Wolff
J E A
JE
D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation; D002648:Child; D004827:Epilepsy / Q000188:drug therapy; D005192:Family Health; D006801:Humans; D008297:Male; D018242:Neuroectodermal Tumors, Primitive / Q000188:drug therapy / Q000473:pathology*; D009457:Neuroglia / Q000187:drug effects; D012008:Recurrence; D015173:Supratentorial Neoplasms / Q000188:drug therapy / Q000473:pathology*; D014635:Valproic Acid / Q000494:pharmacology*
D014635:Valproic Acid